Making access to critical drugs
possible around the globe

Making access to critical drugs
possible around the globe

Hetero ‘Global Access’ is a business vertical dedicated to managing the supply of quality medicines to renowned global procurement bodies. We have legacy of treating HIV/AIDS since 1997, making us one of the global leaders in production and supply of affordable ARV APIs and Formulations. About 30+ of our ARV combinations cater to ~40%* of identified HIV/AIDS patients’ treatment worldwide.

Launched the world’s first-ever fixed dosage combinations such as Darunavir + Ritonavir and Emtricitabine + Tenofovir Alafenamide, underscoring our expertise in ARVs

Among the first in India and around the world to introduce a portfolio of life-saving hepatitis drugs such as Sofosbuvir and fixed-dose combination therapies through global licensing agreements

*Ref: Either API or FDF. Data on file


Countries where our products are marketed


Product registrations with local regulatory authorities


ARV drugs in portfolio

Explore more

Know more about our Key therapies